MILLENNIUM MANAGEMENT LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 54 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q3 2020$445,000
+509.6%
404,398
+663.5%
0.00%
Q2 2020$73,000
-24.0%
52,966
-37.3%
0.00%
Q1 2020$96,000
+29.7%
84,536
-3.7%
0.00%
Q3 2019$74,000
-73.1%
87,787
-68.9%
0.00%
Q2 2019$275,000
-72.1%
282,216
-63.9%
0.00%
-100.0%
Q1 2019$984,000
-51.6%
780,916
+24.4%
0.00%
-66.7%
Q4 2018$2,034,000
+101.2%
627,915
+194.9%
0.00%
+200.0%
Q1 2018$1,011,000
-81.8%
212,891
-77.7%
0.00%
-87.5%
Q4 2017$5,559,000
+1382.4%
953,513
+434.2%
0.01%
+700.0%
Q3 2017$375,000
-30.2%
178,494
+55.5%
0.00%0.0%
Q2 2017$537,000
-42.2%
114,752
-3.4%
0.00%
-50.0%
Q1 2017$929,000
-73.8%
118,738
-58.9%
0.00%
-71.4%
Q4 2016$3,543,000
+17.8%
289,002
+49.8%
0.01%
+40.0%
Q3 2016$3,007,000
+977.8%
192,900
+738.2%
0.01%
+400.0%
Q2 2016$279,000
+181.8%
23,013
+123.7%
0.00%
Q1 2016$99,00010,2870.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q4 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,350,000$36,636,0004.04%
EcoR1 Capital, LLC 602,315$9,390,0002.88%
NEA Management Company, LLC 3,556,778$55,450,0002.49%
Opaleye Management Inc. 152,000$2,370,0001.24%
Avoro Capital Advisors LLC 179,565$2,799,0000.49%
Monashee Investment Management LLC 85,000$1,325,0000.47%
Rock Springs Capital Management LP 450,000$7,016,0000.44%
Perceptive Advisors 344,550$5,372,0000.35%
Hillhouse Capital Management 763,790$11,907,0000.24%
Eventide Asset Management 220,000$3,430,0000.21%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders